Connection

Kate Traynor to United States

Back to Details
This is a "connection" page, showing publications Kate Traynor has written about United States.
Kate Traynor
Connection Strength
0.174
United States
  1. Senators acknowledge importance of 340B program. Am J Health Syst Pharm. 2018 Jul 01; 75(13):925-926.
    View in: PubMed
    Score: 0.027
  2. FDA approves nonopioid medication for managing opioid withdrawal. Am J Health Syst Pharm. 2018 Jul 01; 75(13):927.
    View in: PubMed
    Score: 0.027
  3. FDA approves licensing of erenumab-aooe to prevent migraine. Am J Health Syst Pharm. 2018 Jul 01; 75(13):929-930.
    View in: PubMed
    Score: 0.027
  4. OPPS continues ASP-plus-6% reimbursement rate for 2014. Am J Health Syst Pharm. 2014 Jan 15; 71(2):90-2.
    View in: PubMed
    Score: 0.020
  5. Obinutuzumab approved for CLL: Monoclonal antibody product is first FDA-approved breakthrough therapy. Am J Health Syst Pharm. 2013 Dec 15; 70(24):2162.
    View in: PubMed
    Score: 0.020
  6. REMS review explores programs' burdens. Am J Health Syst Pharm. 2012 Jan 15; 69(2):92, 94.
    View in: PubMed
    Score: 0.017
  7. Growth of REMS challenges FDA, stakeholders. Am J Health Syst Pharm. 2010 Aug; 67(15):1221-2.
    View in: PubMed
    Score: 0.015
  8. FDA holds public meeting on nanotechnology. Am J Health Syst Pharm. 2006 Nov 15; 63(22):2175-7.
    View in: PubMed
    Score: 0.012
  9. JCAHO unveils medication-management standards. Am J Health Syst Pharm. 2003 Jul 15; 60(14):1400, 1402.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.